Peripheral Artery Disease (PAD): Risk Factors, Diagnosis and Treatment
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Acquired Cardiovascular Disease".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 11272
Special Issue Editor
Special Issue Information
Dear Colleagues,
Peripheral artery disease (PAD), also called peripheral arterial disease, is a common circulatory problem encompassing a range of atherosclerotic and aneurysmal conditions within the extra-coronary circulation. PAD affects millions of people around the world, and significantly increases the risk of cardiovascular events in affected patients.
The risk factors include, but are not limited to, advanced age, smoking, physical inactivity, diabetes, obesity, thrombosis, dyslipidemia, inflammation, and microvascular disease. PAD can increase the risk of heart attack, stroke, and transient ischemic attack, limb amputation, and even death. Doctors diagnose PAD with a physical exam and different tools depending on the disease stage. Treatments include lifestyle changes, medicines, and occasionally surgery. Lifestyle changes include dietary changes and exercise and the medicines used are antihypertensive drugs, statins, antiplatelet drugs, etc. More advanced PAD may require surgical treatment, including balloon angioplasty, stents, peripheral artery bypass surgery, and atherectomy.
This Special Issue aims to include research related to PAD that addresses risk factor analysis, imaging technologies, diagnostic tools, clinical applications, or treatment strategies.
Dr. Zoltán Ruzsa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peripheral artery disease
- PAD
- atherosclerosis
- aneurysm
- endovascular treatment
- angioplasty
- stents
- dyslipidemia
- stroke
- limb ischemia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.